Galit Frydman Discusses JTH Research on Cerebral Vein Thrombosis Risk from Hormonal Contraceptives
Galit Frydman, Founder and Chief Scientific Officer of Coagulo Medical Technologies, Inc., reposted from Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:
“Yet another example of how femtech needs more attention. Hormonal birth control is such a popular form of birth control, yet it can pose life-threatening adverse events to the woman using it.
I never realized how much women’s, maternal and fetal medicine was behind until I had my own pregnancy and child.
The market size is not a question here….why is funding and why are companies so far behind on these issues? (lots of reasons for this! but I thought it would start an interesting conversation on this platform)”
Journal of Thrombosis and Haemostasis (JTH) has shared a post on LinkedIn:
“The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study
In this case-control study of 206 women with CVT and 868 controls, combined hormonal contraceptive (CHC) use was associated with a 10-fold higher risk of CVT. Risk increased with higher estrogen doses and was particularly elevated with fourth-generation pills (OR 28.3). Progestin-only and variable-dose CHCs carried a 6-fold increased risk. Importantly, thrombophilia and positive family history had synergistic effects, with odds ratios exceeding 200 in some subgroups.”
Title: The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study
Authors: Maria Abbattista, Addolorata Truma, Ida Martinelli, Francesca Gianniello, Serena M. Passamonti, Marco Capecchi, Andrea Artoni, Flora Peyvandi, Paolo Bucciarelli

Read the full article here.
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026